Advertisement

High-Dose-Rate Intraluminal Brachytherapy for Small Superficial Esophageal Carcinoma

  • Koichi Kurisu
  • Yoshio Hishikawa
  • Masayuki Izumi
  • Midori Taniguchi
  • Norihiko Kamikonya
Conference paper

Abstract

Recent remarkable progress in high-dose-rate intraluminal brachytherapy (HDRIBT) has contributed to the treatment of esophageal cancer. This method is particularly effective for patients with early disease stage [1, 2]. We previously reported that a complete response was gained by HDRIBT alone in the patients with small superficial esophageal cancer and the treatment protocol of HDRIBT alone was recommended for these patients [3, 4]. However, a longer period of observation revealed different results. In this study, our purpose is to analyze local control, regional lymph node control, and survival relative to three radiotherapy protocols combined with HDRIBT for superficial esophageal carcinoma. We will describe the disadvantage of HDRIBT alone for patients with small superficial esophageal cancer; this method should be limited to patients with serious systemic disease.

Keywords

Esophageal Cancer Esophageal Carcinoma Regional Lymph Node Metastasis Cervical Lymph Node Metastasis Occult Lymph Node Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hishikawa Y, Tanaka S, Miura T (1985) Early esophageal carcinoma treate with intracavitary irradiation. Radiology 156: 519–522PubMedGoogle Scholar
  2. 2.
    Hishikawa Y, Kamikonya N, Tanaka S, Miura T (1987) Radiotherapy of esophageal carcinoma: Role of high-dose-rate intracavitary irradiation. Radiother Oncol 9: 13–20PubMedCrossRefGoogle Scholar
  3. 3.
    Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T (1989) Small, superficial esophageal carcinoma treated with high-dose-rate intracavitary irradiation only. Radiology 172: 267–270PubMedGoogle Scholar
  4. 4.
    Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T (1991) High-dose-rate intraluminal brachytherapy ( HDRIBT) for esophageal cancer. Int J Radiat Oncol Biol Phys 21: 1133–1135PubMedCrossRefGoogle Scholar
  5. 5.
    Parker EF, Gregorie HB (1976) Carcinoma of the esophagus: Long-term results. JAMA 235: 1018–1020PubMedCrossRefGoogle Scholar
  6. 6.
    Sugimachi K, Ohno S, Matsuda H, Mori M, Kuwano H, Ide H (1989) Clinicopathologic study of early stage esophageal carcinoma. Surgery 105: 706–710PubMedGoogle Scholar
  7. 7.
    Yoshinaka H, Shimazu H, Fukumoto T, Baba M (1991) Superficial esophageal carcinoma: A clinicopathological review of 59 cases. Am J Gastroenterol 86: 1413–1418PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Koichi Kurisu
  • Yoshio Hishikawa
  • Masayuki Izumi
  • Midori Taniguchi
  • Norihiko Kamikonya
    • 1
  1. 1.Department of RadiologyHyogo College of MedicineNishinomiya Hyogo, 663Japan

Personalised recommendations